Motus GI Holdings Interest Expense 2011-2025 | MOTS

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Motus GI Holdings

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
211	128	453 K	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
453 K	128	151 K

Quarterly Interest Expense Motus GI Holdings

2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
85 K	-	281 K	285 K	308 K	-	338 K	356 K	327 K	-	193 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
356 K	85 K	272 K

Interest Expense of other stocks in the Diagnostics research industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	8.42 M	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	118 M	-	-17.87 %	$ 25.9 M	Canada
Burning Rock Biotech Limited BNR	1.54 M	$ 16.9	7.3 %	$ 183 M	China
Accelerate Diagnostics AXDX	235 K	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	316 K	-	-13.05 %	$ 7.29 M	USA
BioNano Genomics BNGO	-10.1 M	$ 1.57	-3.08 %	$ 2 M	USA
Castle Biosciences CSTL	1 K	$ 38.44	-0.5 %	$ 1.07 B	USA
DarioHealth Corp. DRIO	-31 K	$ 12.0	0.93 %	$ 340 M	Israel
Chembio Diagnostics CEMI	2.94 K	-	0.22 %	$ 16.8 M	USA
DexCom DXCM	20.3 M	$ 66.39	-0.85 %	$ 25.6 B	USA
Danaher Corporation DHR	-56 M	$ 226.5	-	$ 166 B	USA
Exact Sciences Corporation EXAS	18.6 M	$ 101.57	0.07 %	$ 18.8 B	USA
Fulgent Genetics FLGT	561 K	$ 26.81	-1.22 %	$ 811 M	USA
Global Cord Blood Corporation CO	6.27 M	-	-	$ 399 M	China
Genetic Technologies Limited GENE	15.2 K	-	-	$ 7.1 B	Australia
DermTech DMTK	-355 K	-	-11.32 %	$ 2.94 M	USA
CareDx, Inc CDNA	1.34 M	$ 19.74	-3.99 %	$ 1.06 B	USA
Celcuity CELC	2.11 M	$ 102.0	-3.09 %	$ 4.02 B	USA
Enzo Biochem ENZ	494 K	-	-8.98 %	$ 14.8 K	USA
Anixa Biosciences ANIX	500 K	$ 3.53	-1.4 %	$ 113 K	USA
Co-Diagnostics CODX	106 K	$ 0.31	-9.4 %	$ 9.1 M	USA
IQVIA Holdings IQV	670 M	$ 222.3	0.04 %	$ 40.3 B	USA
Guardant Health GH	-42.6 M	$ 103.47	1.37 %	$ 12.7 B	USA
Aspira Women's Health AWH	106 K	-	-6.19 %	$ 10.5 M	USA
Heska Corporation HSKA	4.19 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	857 K	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	-292 M	$ 133.88	-0.73 %	$ 21.3 B	USA
Charles River Laboratories International CRL	-16.5 M	$ 196.14	1.64 %	$ 10.1 B	USA
Quotient Limited QTNT	2.72 M	-	-11.32 %	$ 1.1 M	Schweiz
Quest Diagnostics Incorporated DGX	30 M	$ 183.36	0.47 %	$ 20.4 B	USA
Biodesix BDSX	8.26 M	$ 7.56	-3.63 %	$ 980 M	USA
Mettler-Toledo International MTD	74.6 M	$ 1 410.24	1.17 %	$ 29.9 B	Schweiz
Laboratory Corporation of America Holdings LH	208 M	$ 262.29	-0.71 %	$ 22 B	USA
Myriad Genetics MYGN	1.1 M	$ 7.01	-2.84 %	$ 635 M	USA
ICON Public Limited Company ICLR	337 M	$ 183.39	-1.71 %	$ 15.1 B	Irlanda
IDEXX Laboratories IDXX	29.8 M	$ 701.16	-0.43 %	$ 57.8 B	USA
Lantheus Holdings LNTH	37.2 M	$ 67.34	1.08 %	$ 4.66 B	USA
NeoGenomics NEO	-379 K	$ 12.07	1.81 %	$ 1.53 B	USA
Neogen Corporation NEOG	38.1 M	$ 6.8	-0.95 %	$ 1.47 B	USA
Agilent Technologies A	81 M	$ 140.63	0.69 %	$ 42.8 B	USA
Biomerica BMRA	367	$ 2.56	0.29 %	$ 5.88 M	USA
Bioventus BVS	1.29 M	$ 7.59	0.53 %	$ 475 M	USA
Check-Cap Ltd. CHEK	13 K	-	-	$ 9.42 M	Israel